CuriosityStream Statistics
Total Valuation
CURI has a market cap or net worth of $85.44 million. The enterprise value is $56.22 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | Oct 11, 2024 |
Share Statistics
CURI has 55.48 million shares outstanding. The number of shares has increased by 1.47% in one year.
| Current Share Class | 55.48M |
| Shares Outstanding | 55.48M |
| Shares Change (YoY) | +1.47% |
| Shares Change (QoQ) | +2.31% |
| Owned by Insiders (%) | 46.93% |
| Owned by Institutions (%) | 8.84% |
| Float | 29.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.60 |
| Forward PS | 1.55 |
| PB Ratio | 1.37 |
| P/TBV Ratio | 3.02 |
| P/FCF Ratio | 33.19 |
| P/OCF Ratio | 33.19 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.60, with an EV/FCF ratio of 21.84.
| EV / Earnings | n/a |
| EV / Sales | 1.09 |
| EV / EBITDA | 9.60 |
| EV / EBIT | n/a |
| EV / FCF | 21.84 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.90 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.63 |
| Debt / FCF | 1.55 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.25% and return on invested capital (ROIC) is -12.05%.
| Return on Equity (ROE) | -21.25% |
| Return on Assets (ROA) | -9.17% |
| Return on Capital (ROIC) | -12.05% |
| Revenue Per Employee | $1.08M |
| Profits Per Employee | -$308,063 |
| Employee Count | 48 |
| Asset Turnover | 0.53 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CURI has paid $161,000 in taxes.
| Income Tax | 161,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +184.66% in the last 52 weeks. The beta is 1.08, so CURI's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +184.66% |
| 50-Day Moving Average | 1.97 |
| 200-Day Moving Average | 1.41 |
| Relative Strength Index (RSI) | 37.16 |
| Average Volume (20 Days) | 168,112 |
Short Selling Information
The latest short interest is 267,609, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 267,609 |
| Short Previous Month | 325,550 |
| Short % of Shares Out | 0.48% |
| Short % of Float | 0.91% |
| Short Ratio (days to cover) | 1.03 |
Income Statement
In the last 12 months, CURI had revenue of $51.78 million and -$14.79 million in losses. Loss per share was -$0.28.
| Revenue | 51.78M |
| Gross Profit | 25.06M |
| Operating Income | -14.22M |
| Pretax Income | -45.70M |
| Net Income | -14.79M |
| EBITDA | 5.86M |
| EBIT | -14.22M |
| Loss Per Share | -$0.28 |
Full Income StatementBalance Sheet
The company has $33.21 million in cash and $3.99 million in debt, giving a net cash position of $29.22 million or $0.53 per share.
| Cash & Cash Equivalents | 33.21M |
| Total Debt | 3.99M |
| Net Cash | 29.22M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 62.22M |
| Book Value Per Share | 1.12 |
| Working Capital | 18.53M |
Full Balance SheetCash Flow
| Operating Cash Flow | 2.57M |
| Capital Expenditures | n/a |
| Free Cash Flow | 2.57M |
| FCF Per Share | $0.05 |
Full Cash Flow StatementMargins
Gross margin is 48.40%, with operating and profit margins of -27.46% and -28.56%.
| Gross Margin | 48.40% |
| Operating Margin | -27.46% |
| Pretax Margin | -28.25% |
| Profit Margin | -28.56% |
| EBITDA Margin | 11.32% |
| EBIT Margin | -27.46% |
| FCF Margin | 4.97% |
Dividends & Yields
This stock pays an annual dividend of $0.10, which amounts to a dividend yield of 6.49%.
| Dividend Per Share | $0.10 |
| Dividend Yield | 6.49% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.47% |
| Shareholder Yield | 5.02% |
| Earnings Yield | -17.31% |
| FCF Yield | 3.01% |
Dividend DetailsAnalyst Forecast
The average price target for CURI is $3.00, which is 94.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 94.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CURI has an Altman Z-Score of -3.39 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.39 |
| Piotroski F-Score | 4 |